We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Hepatothin (Ferngrove Pharmaceuticals Australia Pty Ltd)
Product Name
Hepatothin
ARTG details
- 408405
Date of review outcome
Date of publication
Dec-2025
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Consider whether this medicine is right for you based on it potentially not working as expected in relation to supporting liver regeneration
Review scope
Targeted
Information reviewed
ARTG Record, Labels
Issues related to safety
The safety of this medicine was not assessed as part of this review
Issues related to efficacy
The label for this medicine claimed it supports liver regeneration. However, this claim was not covered by the sponsor's certification that they held evidence to substantiate it.
Actions taken during the review
The sponsor cancelled this medicine and withdrew it from further supply. Nevertheless, the TGA issued an educational letter to the sponsor outlining the issues with this medicine.